We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Single Step, Direct ELISA Measures Free Testosterone

By LabMedica International staff writers
Posted on 18 Sep 2012
A single-step direct ELISA measurement of free testosterone saves laboratories time and money while reducing the possibility of errors.

The ability to directly measure free testosterone eliminates the complication of taking multiple indirect measurements and calculating free testosterone through an algorithm. More...
Diagnostic technologies have inherent limitations in terms of both precision and accuracy. Combining multiple procedures worsens these limitations and increases both the cost and opportunity for errors.

The ThunderBolt delivers power and flexibility in a small size. The dual function analyzer provides complete, walk-away automation of 192 patient samples in only a 61 cm by 61 cm space. Completely open architecture allows any enzyme immunoassay (EIA) or clinical laboratory improvement amendments (CLIA) protocol to be programmed. Up to eight different protocols can run in a single batch. Intuitive and robust software further enriches the ThunderBolt, making it the total laboratory automation solution. The ThunderBolt delivers power and flexibility in a small size.

The combination of free and total testosterone gives healthcare professionals more information to make the correct diagnosis when a testosterone-related condition is suspected. Gold Standard Diagnostics (GSD; Davis, CA, USA) also offers an ELISA test for total testosterone level to complement the free testosterone assay.

Total testosterone measures levels of all forms in the blood stream, including: unbound (free), loosely bound to albumin and tightly bound to sex-hormone binding globulin (SHBG). Many common factors influence SHBG levels. As a result, a total testosterone assessment may yield a normal result, but due to higher or lower levels of testosterone-SHBG bonding, the concentration of free testosterone may not correlate directly with total testosterone readings.

SHBG levels can be increased by factors such as obesity and testosterone treatment. Factors that can decrease SHBG levels include aging, pregnancy, and estrogen therapy. Symptoms of low testosterone in males include decreased sexual function, erectile dysfunction, loss of hair, decreased muscle mass, and osteoporosis. For females, symptoms include hot flashes, irritability, decreased libido, and insomnia.

Gold Standard Diagnostics (GSD) provides comprehensive diagnostic solutions that improve lab efficiency and minimize overall costs. Through an extensive product menu, automated instrument platforms, and good customer service, GSD solves laboratory problems.

Related Links:

Gold Standard Diagnostics



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Immunofluorescence Analyzer
IFA System
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.